NASDAQ
Pathfinder Cell Therapy, Inc. (PFND) has a fcf yield of -180.43% as of Friday, May 29, 2026. This represents a 1595.14% decrease compared to its 12-month average of -10.64%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.